What do frozen samurai warriors and magic goggles have to do with treating cancer?
Join Precision BioSciences Chief Science Officer Derek Jantz on a journey into the future of cancer therapies and learn how ARCUS—Precision's genome editing technology—is used to make allogenic, donor-derived CAR T cell therapies with the potential to change the way the world battles cancer.